HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Press releases
April 13, 2021
HTL Biotechnology & Echelon Biosciences strategic partnership
The partnership provides academic research and pharmaceutical development laboratories’expanded access to Good Manufacturing Practices (GMP)-grade, kit-packaged hyaluronic acid and glycosaminoglycan (GAG) products.
By offering premium, clinical grade products to early-stage research investigators, the partnership seeks to bridge the gap between lab-based research, development and commercialization, and accelerate innovation worldwide.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles September 13, 2025Looking Back at Our Presence at ESCRS 2025
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.
-
Articles July 23, 20252024 CSR Report is now available!
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
-
Articles June 12, 2025Strong Presence at ISHAS Congress 2025 in the USA
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.